Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Summary
The goal of this prospective study is to assess the performance of AI (artificial intelligence) augmentation (compared against historical controls) to identify oncology patients who meet inclusion criteria for a clinical trial. The study staff will leverage a natural language processing (NLP)-based AI algorithm that rank-orders patients most likely to meet inclusion criteria for a trial. We hypothesize that this collaborative Human+AI workflow can improve the efficiency, accuracy, and diversity of trial prescreening.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Efficiency
Secondary study objectives
Accuracy
Diversity
Trial Design
1Treatment groups
Experimental Treatment
Group I: Human + AIExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,053 Previous Clinical Trials
43,012,827 Total Patients Enrolled
7 Trials studying Prostate Cancer
3,697 Patients Enrolled for Prostate Cancer
Mendel AIIndustry Sponsor
2 Previous Clinical Trials
417 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger